Current Report
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: December
31, 2002
(Date of earliest event reported)
TIVO INC.
(exact name
of registrant as specified in its charter)
|
|
Commission File: 000-27141 |
|
|
|
Delaware |
|
|
|
77-0463167 |
(State or other jurisdiction of incorporation or organization) |
|
|
|
(I.R.S. Employer Identification
No.) |
2160 Gold Street
P.O. Box 2160
Alviso, California 95002
(Address of Principal executive offices, including zip code)
(408) 519-9100
(Registrants telephone number, including area code)
ITEM 5. OTHER EVENTS
On December 20, 2002, we entered into an Amendment to the product development agreement dated February 15, 2002 with DIRECTV, Inc. The amendment revises provisions relating
to, among other things, the specifications, development schedules, milestone payment schedule and transition services for the development and manufacture of Series2 DIRECTV receivers and new versions of the associated client software.
ITEM 7. FINANCIAL STATEMENT, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
Exhibit Number
|
|
Description
|
|
10.1+ |
|
Second Amendment to the Development Agreement dated as of December 20, 2002 by and between TiVo Inc. and DIRECTV, Inc. |
+ Confidential treatment has been requested as to portions of this
exhibit.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized,
|
|
|
|
TIVO INC. |
|
Date: December 31, 2002 |
|
|
|
By: |
|
/s/ David H. Courtney
|
|
|
|
|
|
|
David H. Courtney Chief Financial Officer
and Executive Vice President Worldwide Operations and
Administration (Principal Financial and Accounting Officer) |
EXHIBIT INDEX
Exhibit Number
|
|
Description
|
|
10.1+ |
|
Second Amendment to the Development Agreement dated as of December 20, 2002 by and between TiVo Inc. and DIRECTV, Inc. |
+ Confidential treatment has been requested as to
portions of this exhibit.